Ad.B.O.C. 2017
Speakers
For this one-day symposium we have invited both Academic and Industrial speakers to share with you there latest results and discoveries
Dr. Michael Ingleson
University of Manchester
Manchester - UK
New Routes to sp2C-Boronate Esters Using Just Simple Boron Electrophiles
Dr Ingleson obtained his MChem degree from the University of Bath (UK) in 2004, where he began his research career as a PhD Student under Prof Andrew S. Weller in Organometallic Chemistry. He then carried out Post-doctoral studies. The first one with Prof. Ken Caulton at Indiana University (USA) and the second under Prof. Matt Rosseinsky in the University of Liverpool which then lead him to take a position of Royal Society University Research Fellow at the University of Manchester (UK) in 2008. Since 2012 he occupies the position of Reader in Chemistry in the same University. He was awarded the Young International Boron Chemistry prize at IMEBORON XIV in 2011 and the RSC Harrison-Meldola prize in 2012 for his innovative work in borocation chemistry. The Ingleson Group studies the fundamental and applied properties of boron compounds, other main group electrophiles and low toxicity, inexpensive transition metal catalysts.
Prof. Maria Elena Fernández Gutiérrez
Universitat Rovira i Virgili
Tarragona - Spain
Complementary synthesis of allylboracycles to populate the chemical functionality to a given area of biological interest
Prof Fernández obtained her MChem degree from the University of Barcelona (Spain) in 1991. She began her research career with a PhD in catalytic hydroformylation of sugars with Prof. Sergio Castillón and Dr. Aurora Ruiz at the University Rovira i Virgili (Spain). She then carried out Post-doctoral studies with Prof. John M. Brown at the University of Oxford (UK) where she developed an approach towards the first catalytic asymmetric hydroboration-amination reaction. She finally returned to Tarragona to take a lecturer position at the University Rovira i Virgili and was awarded with permanent staff status in 2000. Since then she is full professor from the ANECA (National Agency for Quality Assessment and Accreditation) of Spain in 2011 and obtained the National Award on Excellence of Research in Organometallic Chemistry in 2014 from the Spanish RSC. As of 2010 she is a member of the scientific committee of the Euroboron and as of 2014 also a member of the Advisory board in Chemical Society Reviews (Chem. Soc. Rev.). Research in the Fernández group focusses on finding new concepts for the activation and reactivity of borane compounds.
Dr. María Méndez Pérez
Sanofi-Aventis Deutschland GmbH
Frankfurt - Germany
Title:
Dr. María Méndez Pérez obtained her MChem degree from the Autonomous University of Madrid (Spain) where she began her research career as a PhD student with Prof. Antonio M. Echavarren in transition metal catalysis. After obtaining her PhD as Summa Cum Laude in 2001 she moved to Germany for a Post-Doctoral position with both Prof. Dr. Alois Fürstner in the MPI in Mülheim and subsequently with Prof. van Wüllen in the Technische Universität Berlin, where she further worked in catalysis including some theoretical aspects. In 2006, she joined Sanofi-Aventis in Frankfurt (Germany) where she works now as a Senior Scientist in medicinal chemistry. She has worked in a number of different projects lately with focus in metabolic diseases.
Craig Johnstone
Title
Dr. Michael Ingleson
University of Manchester
Manchester - UK
New Routes to sp2C-Boronate Esters Using Just Simple Boron Electrophiles
Dr Ingleson obtained his MChem degree from the University of Bath (UK) in 2004, where he began his research career as a PhD Student under Prof Andrew S. Weller in Organometallic Chemistry. He then carried out Post-doctoral studies. The first one with Prof. Ken Caulton at Indiana University (USA) and the second under Prof. Matt Rosseinsky in the University of Liverpool which then lead him to take a position of Royal Society University Research Fellow at the University of Manchester (UK) in 2008. Since 2012 he occupies the position of Reader in Chemistry in the same University. He was awarded the Young International Boron Chemistry prize at IMEBORON XIV in 2011 and the RSC Harrison-Meldola prize in 2012 for his innovative work in borocation chemistry. The Ingleson Group studies the fundamental and applied properties of boron compounds, other main group electrophiles and low toxicity, inexpensive transition metal catalysts.
Prof. Maria Elena Fernández Gutiérrez
Universitat Rovira i Virgili
Tarragona - Spain
Complementary synthesis of allylboracycles to populate the chemical functionality to a given area of biological interest
Prof Fernández obtained her MChem degree from the University of Barcelona (Spain) in 1991. She began her research career with a PhD in catalytic hydroformylation of sugars with Prof. Sergio Castillón and Dr. Aurora Ruiz at the University Rovira i Virgili (Spain). She then carried out Post-doctoral studies with Prof. John M. Brown at the University of Oxford (UK) where she developed an approach towards the first catalytic asymmetric hydroboration-amination reaction. She finally returned to Tarragona to take a lecturer position at the University Rovira i Virgili and was awarded with permanent staff status in 2000. Since then she is full professor from the ANECA (National Agency for Quality Assessment and Accreditation) of Spain in 2011 and obtained the National Award on Excellence of Research in Organometallic Chemistry in 2014 from the Spanish RSC. As of 2010 she is a member of the scientific committee of the Euroboron and as of 2014 also a member of the Advisory board in Chemical Society Reviews (Chem. Soc. Rev.). Research in the Fernández group focusses on finding new concepts for the activation and reactivity of borane compounds.
Dr. María Méndez Pérez
Sanofi-Aventis Deutschland GmbH
Frankfurt - Germany
Title:
Dr. María Méndez Pérez obtained her MChem degree from the Autonomous University of Madrid (Spain) where she began her research career as a PhD student with Prof. Antonio M. Echavarren in transition metal catalysis. After obtaining her PhD as Summa Cum Laude in 2001 she moved to Germany for a Post-Doctoral position with both Prof. Dr. Alois Fürstner in the MPI in Mülheim and subsequently with Prof. van Wüllen in the Technische Universität Berlin, where she further worked in catalysis including some theoretical aspects. In 2006, she joined Sanofi-Aventis in Frankfurt (Germany) where she works now as a Senior Scientist in medicinal chemistry. She has worked in a number of different projects lately with focus in metabolic diseases.
Dr. Craig Johnstone
Boron chemistry in drug discovery – an excellent servant, (probably) a terrible master
Dr Craig Johnstone FRSC CChem (EVP, Global Head of Chemistry) is a successful research leader with over 20 years’ experience of molecular design and drug discovery in diabetes, obesity, inflammation and oncology. Craig conducted his PhD, studying the application of the organometallic Pauson-Khand reaction to natural product syntheses, under the supervision of Prof WJ Kerr at the University of Strathclyde, before joining Zeneca Pharmaceuticals in 1994. Through Zeneca, AstraZeneca, Prosidion and Evotec, Craig has worked in drug discovery in a number of different environments. Additionally, Craig has developed a keen interest in the interface between creativity, innovation and process excellence for high-performance drug discovery. Craig has led teams and groups which have discovered 16 candidate drugs for development and had published more than 70 patents and papers in drug discovery, medicinal and synthetic chemistry, innovation and process excellence.
